Versantis is a developer of liver disease therapeutics and diagnostics intended to provide the first drug capture platform for the treatment of life-threatening intoxications. The company's pharmaceutical services offer novel antidotes, that focus on treatment for acute-on-chronic liver failure (ACLF), support the affected organs (liver, kidneys, brain) and encourage liver regeneration, enabling ACLF patients to receive life-saving therapies.
|Employees (est.) (Feb 2020)||6|
Versantis total Funding
Versantis latest funding size
Time since last funding
|5 months ago|
|MassChallenge, Esperante Ventures, Altus Capital Partners, Zürcher Kantonal Bank, HealthEquity, Venture Kick, RedAlpine, OCCIDENT, Swisscanto Invest|
Versantis has 112 Twitter Followers. The number of followers has increased 4.9% month over month and increased 9.1% quarter over quarter
When was Versantis founded?
Versantis was founded in 2015.
Who are Versantis key executives?
Versantis's key executives are Vincent Forster, Meriam Kabbaj and Sophie Biguenet.
How many employees does Versantis have?
Versantis has 6 employees.
Who are Versantis competitors?
Competitors of Versantis include AlzeCure Pharma, Jubilant Radiopharma and Igyxos.
Where is Versantis headquarters?
Versantis headquarters is located at Technoparkstrasse & 1, Zürich.
Where are Versantis offices?
Versantis has an office in Zürich.
How many offices does Versantis have?
Versantis has 1 office.
Receive alerts for 300+ data fields across thousands of companies